| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $252.4M | +2.1% | +11.2% |
| Cost of Revenue | $56.8M | +4.3% | +12.4% |
| Gross Profit | $195.7M | +1.5% | +10.8% |
| R&D Expense | $56.3M | -5.0% | +17.2% |
| SG&A Expense | $32.3M | -4.8% | +2.4% |
| Operating Income | $7.1M | +195.8% | +442.6% |
| Income Tax | $550K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $171.9M | -1.8% | -45.0% |
| Short-term Investments | $211.7M | +0.1% | -10.4% |
| Accounts Receivable | $201.0M | +11.0% | +4.3% |
| Current Assets | $679.3M | +1.0% | -19.5% |
| Total Assets | $1.65B | -0.2% | +1.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $183.7M | — | — |
| Capital Expenditures | $11.8M | — | — |
| Investing Cash Flow | -$170.3M | — | — |
| Financing Cash Flow | -$171.2M | — | — |
| Free Cash Flow | $172.0M | — | — |
| -87.0% |
| -89.7% |
| Net Income | $2.3M | +115.4% | +124.5% |
| EPS (Basic) | $0.02 | +116.7% | +125.0% |
| EPS (Diluted) | $0.02 | +116.7% | +125.0% |
| $720.3M |
| +1.0% |
| +9.6% |
| Total Liabilities | $1.31B | +0.2% | +6.4% |
| Stockholders' Equity | $344.4M | -1.8% | -14.9% |